---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-023497"
form_type: "8-K"
ticker: "LYRA"
cik: "0001327273"
company_name: "Lyra Therapeutics, Inc."
filed_at: "2022-06-17T23:59:59+00:00"
generated_at: "2026-06-25T00:46:27.939929+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Lyra Therapeutics stockholders elect three Class II directors and ratify auditor at annual meeting

## Summary
- Michael Altman, C. Ann Merrifield, and Harlan Waksal elected as Class II directors with votes for 19.7M-19.8M each; 2.5M broker non-votes.
- Ratification of BDO USA as independent auditor for FY2022: 22.3M for, 25.5K against, 16.5K abstained.
- Approximately 70.19% of outstanding shares (22.3M of ~31.8M) represented at the meeting.

## SEC filing metadata
- accession: 0001564590-22-023497
- form_type: 8-K
- ticker: LYRA
- cik: 0001327273
- company_name: Lyra Therapeutics, Inc.
- filed_at: 2022-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1327273/000156459022023497/0001564590-22-023497-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1327273/000156459022023497/lyra-8k_20220616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-023497
- JSON: https://secwatch.observer/filing/0001564590-22-023497.json
- Plain text: https://secwatch.observer/filing/0001564590-22-023497.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.